Neurology 1505 - Neurology Alert - May 01, 2011

Target Audience:

This activity is intended for the neurologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Matthew Fink, MD
Vice Chairman, Professor of Clinical Neurology
Weill Medical College
Chief of Division of Stroke and Critical Care Neurology
NewYork Presbyterian Hospital

Peer Reviewer
M. Flint Beal, MD
Professor and Chairman,
Department of Neurology and Neuroscience

Assistant Editors
Claire Henchcliffe, MD
Associate Professor of Neurology and Neuroscience
Weill Cornell Medical Center

John Caronna, MD
Professor of Clinical Neurology
Weill Cornell Medical College

Michael Rubin, MD, FRCP(C)

Professor of Clinical Neurology;
Specialty area, Neuromuscular Disorders

Padmaja Kandula, MD
Assistant Professor of Neurology and Neuroscience
Comprehensive Epilepsy Center
Weill Medical College

Authors
Halinder S. Mangat, MD
Assistant Professor of Clinical Neurology
Weill Cornell Medical College

Subjects:

  • First Successful Surgical Trial for Gene Therapy in Parkinson's Disease
  • Early Prediction of Long-Term Outcome After Traumatic Spinal Cord Injury
  • Flu Shots and Myasthenia Gravis
  • Decompressive Craniectomy for Severe Diffuse TBI
  • Genetic Susceptibility to Fatal Rash from Carbamazepine? The Case for HLA Screening
  • Stroke Alert: A Review of Current Clinical Stroke Literature

Objectives:

  • Present current scientific data regarding diagnosis and treatment of neurologic disease, including stroke, Alzheimer?s disease, transient ischemic attack, and coma
  • Discuss the pathogenesis and treatment of pain
  • Present basic science lessons in brain function
  • Discuss information regarding new drugs for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss nonclinical issues of importance to neurologists, such as the right to die and the physician?s legal obligation to patients with terminal illness

Financial Disclosure:

Neurology Alert's editor in chief, Matthew Fink, MD, reports no consultant, stockholder, speaker’s bureau, research, or other relationships related to this field of study. Assistant editors John Caronna, MD, Michael Rubin, MD, FRCP(C), author Halinder S. Mangat, MD, Padmaja Kandula, MD, and peer reviewer M. Flint Beal, MD, report no consultant, stockholder, speaker’s bureau, research, or other financial relationship with any company having ties to this field of study. Assistant editor Claire Henchcliffe, MD reports she is on the speakers bureau and advisory board for Allergan and Teva; speakers bureau for Boehringer-Ingelheim, GlaxoSmithKline, and Novartis; advisory board for Merz; and is a consultant for Gerson Lehman Group and Guidepoint Global.

Copyright 2011 AHC Media LLC. All rights reserved.